Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn J Caster

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Metabolites|February 25, 2022
The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus ErythematosusMichelle T Barati, Dawn J Caster
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 24, 2023
The Treatment of Primary IgA Nephropathy: Change, Change, ChangeDawn J Caster, Richard A Lafayette
Kidney International|July 21, 2023
One antigen closer to understanding membranous nephropathyDawn J Caster, David W Powell
Advances in Chronic Kidney Disease|November 18, 2019
Utilization of Biomarkers in Lupus NephritisDawn J Caster, David W Powell
Lupus (Los Angeles)|July 5, 2022
Precision Targeting of NF-κB Signaling in Lupus NephritisDawn J Caster, David W Powell
Lupus Science & Medicine|October 30, 2020
<i>TNIP1</i>/ABIN1 and lupus nephritis: reviewMakayla P Brady, Erik A Korte, Dawn J Caster, et al.
Kidney360|August 2, 2023
Management of Lupus Nephritis: New Treatments and Updated GuidelinesRupali Avasare, Yelena Drexler, Dawn J Caster, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 5, 2018
Precision medicine in lupus nephritis: can biomarkers get us there?Dawn J Caster, Michael L Merchant, Jon B Klein, et al.
Kidney International|December 19, 2016
Characterization of glomerular extracellular matrix by proteomic analysis of laser-captured microdissected glomeruliLiliane Hobeika, Michelle T Barati, Dawn J Caster, et al.
Proteomics. Clinical Applications|April 25, 2015
Changing the concepts of immune-mediated glomerular diseases through proteomicsDawn J Caster, Liliane Hobeika, Jon B Klein, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Metabolites|February 25, 2022
The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus ErythematosusMichelle T Barati, Dawn J Caster
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 24, 2023
The Treatment of Primary IgA Nephropathy: Change, Change, ChangeDawn J Caster, Richard A Lafayette
Kidney International|July 21, 2023
One antigen closer to understanding membranous nephropathyDawn J Caster, David W Powell
Advances in Chronic Kidney Disease|November 18, 2019
Utilization of Biomarkers in Lupus NephritisDawn J Caster, David W Powell
Lupus (Los Angeles)|July 5, 2022
Precision Targeting of NF-κB Signaling in Lupus NephritisDawn J Caster, David W Powell
Lupus Science & Medicine|October 30, 2020
<i>TNIP1</i>/ABIN1 and lupus nephritis: reviewMakayla P Brady, Erik A Korte, Dawn J Caster, et al.
Kidney360|August 2, 2023
Management of Lupus Nephritis: New Treatments and Updated GuidelinesRupali Avasare, Yelena Drexler, Dawn J Caster, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 5, 2018
Precision medicine in lupus nephritis: can biomarkers get us there?Dawn J Caster, Michael L Merchant, Jon B Klein, et al.
Kidney International|December 19, 2016
Characterization of glomerular extracellular matrix by proteomic analysis of laser-captured microdissected glomeruliLiliane Hobeika, Michelle T Barati, Dawn J Caster, et al.
Proteomics. Clinical Applications|April 25, 2015
Changing the concepts of immune-mediated glomerular diseases through proteomicsDawn J Caster, Liliane Hobeika, Jon B Klein, et al.
Pageof 4